Answers are grounded in this paper and cite their sources.
Experiments were conducted to test the hypothesis that tumor-derived transforming growth factor-alpha (TGF-alpha) is responsible for the increased bone resorption and hypercalcemia seen in some malignant diseases. Homogeneous synthetic TGF-alpha prepared by the solid-phase synthesis method stimulated bone resorption directly in vitro in a concentration-dependent manner. Incubation times of 72 hours or more were required to stimulate resorption, which is similar to the time course of bone resorption by epidermal growth factor.
No takes yet. Share an insight, caveat, or question.
Ibbotson et al. (1985) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: